These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10205762)

  • 1. [Proton pump inhibitor in ulcer disease?].
    Secknus R; Mössner J
    Internist (Berl); 1999 Mar; 40(3):325-6. PubMed ID: 10205762
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peptic ulcer in the elderly--endoscopy in suspected ulcer. Therapy always includes proton pump inhibitor].
    Pfaffenbach B; Orth KH; Langer M; Stabenow-Lohbauer U; Lux G
    MMW Fortschr Med; 2000 Jun; 142(24):28-32. PubMed ID: 10895578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ Treatment of peptic ulcers with proton pump inhibitors].
    Holtermüller KH
    Pharm Unserer Zeit; 2005; 34(3):206-9. PubMed ID: 15940953
    [No Abstract]   [Full Text] [Related]  

  • 4. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginkgo biloba, may significantly reduce gastrointestinal pain: it may also reduce the risk of stomach cancer that is associated with the wide-spread use of proton pump inhibitors.
    Eli R
    Med Hypotheses; 2006; 66(6):1244. PubMed ID: 16504419
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs for peptic ulcers.
    Treat Guidel Med Lett; 2004 Feb; 2(18):9-12. PubMed ID: 15529109
    [No Abstract]   [Full Text] [Related]  

  • 7. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
    Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.
    Bursey F; Crowley M; Janes C; Turner CJ
    CMAJ; 2000 Mar; 162(6):817-23. PubMed ID: 10750472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to: Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage.
    Gitlin N; Weaver AL
    Int J Clin Pract; 2006 May; 60(5):609-10; author reply 610-11. PubMed ID: 16700865
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proton pump inhibitors: Tenatoprazole (TU-199)].
    Nakamura T
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():650-4. PubMed ID: 11979864
    [No Abstract]   [Full Text] [Related]  

  • 13. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid-related disorders and use of antisecretory medication.
    Lassen AT
    Dan Med Bull; 2007 Feb; 54(1):18-30. PubMed ID: 17349216
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine].
    MMW Fortschr Med; 2004 Mar; 146(13):61. PubMed ID: 15219139
    [No Abstract]   [Full Text] [Related]  

  • 16. Current indications for acid suppressants in Helicobacter pylori -negative ulcer disease.
    Howden CW; Leontiadis GI
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):401-12. PubMed ID: 11403535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
    Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Gostishchev VK; Evseev MA
    Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proton pump inhibitors in the pharmacy].
    Martin E
    Pharm Unserer Zeit; 2005; 34(3):228-35. PubMed ID: 15940957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.